Diasome Pharmaceuticals Raises $30 Million

Diasome Pharmaceuticals, a Cleveland developer of diabetes therapies, raised $30 million. Funding was led by European investor Medicxi; other investors include the JDRF, Black Beret Life Sciences and anonymous investors.

Read More  >